 A risk with any agent in pre-cancerous syndrome as immune suppression can decreased tumor immunosurvellence.Its mTOR inhibitors active against lymphomas, especially EBV+ lymphomas.The Goal serum trough is 5-15 ng/ml and can consider PCP prophylaxis but usually not needed.